Cox Carrie Smith - May 14, 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role: Director
Signature: /s/ Faye C. Brown, as Attorney-in-Fact for Carrie Smith Cox
Stock symbol: OGN
Transactions as of: May 14, 2025
Transactions value $: $100,591
Form type: 4
Date filed: 5/15/2025, 04:09 PM
Previous filing: May 15, 2025
Next filing: Jun 16, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
COX CARRIE SMITH	Director	C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY	/s/ Faye C. Brown, as Attorney-in-Fact for Carrie Smith Cox	2025-05-15	0001110753

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Purchase	$101K	+12.5K		$8.07	12.5K	May 14, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price (which was $8.06727998, rounded due to character limitations in the price field). These shares were purchased in multiple transactions at prices ranging from $8.059 to $8.07, inclusive. The reporting person undertakes to provide to Organon & Co. ("Organon"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price (which was $8.06727998, rounded due to character limitations in the price field). These shares were purchased in multiple transactions at prices ranging from $8.059 to $8.07, inclusive. The reporting person undertakes to provide to Organon & Co. ("Organon"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.